Suppr超能文献

线粒体移植作为一种治疗心血管疾病的新策略。

Mitochondrial transplantation as a novel therapeutic strategy for cardiovascular diseases.

机构信息

Institute of Medical Research, Northwestern Polytechnical University, Xi'an, 710072, Shaanxi, P.R. China.

Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Fourth Military Medical University, Xi'an, 710032, China.

出版信息

J Transl Med. 2023 May 25;21(1):347. doi: 10.1186/s12967-023-04203-6.

Abstract

Cardiovascular disease (CVD) is the leading cause of noncommunicable disease-related death worldwide, and effective therapeutic strategies against CVD are urgently needed. Mitochondria dysfunction involves in the onset and development of CVD. Nowadays, mitochondrial transplantation, an alternative treatment aimed at increasing mitochondrial number and improving mitochondrial function, has been emerged with great therapeutic potential. Substantial evidence indicates that mitochondrial transplantation improves cardiac function and outcomes in patients with CVD. Therefore, mitochondrial transplantation has profound implications in the prevention and treatment of CVD. Here, we review the mitochondrial abnormalities that occur in CVD and summarize the therapeutic strategies of mitochondrial transplantation for CVD.

摘要

心血管疾病(CVD)是全球与非传染性疾病相关死亡的主要原因,迫切需要有效的治疗策略来对抗 CVD。线粒体功能障碍与 CVD 的发生和发展有关。如今,线粒体移植作为一种旨在增加线粒体数量和改善线粒体功能的替代治疗方法,已经具有很大的治疗潜力。大量证据表明,线粒体移植可改善 CVD 患者的心脏功能和预后。因此,线粒体移植对 CVD 的预防和治疗具有深远的意义。在这里,我们回顾了 CVD 中发生的线粒体异常,并总结了线粒体移植治疗 CVD 的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6404/10210445/f578110ab3fe/12967_2023_4203_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验